Atlas Trials

Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology

Clinical trial NCT05742568 · COMPLETED

Trial details

NCT number
NCT05742568
Sponsor
Xijing Hospital of Digestive Diseases
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
GastritisDyspepsiaHelicobacter Pylori InfectionGastric CancerPeptic Ulcer
Start date
2022-12-01
Primary completion
2023-12-02
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.